» Articles » PMID: 17962200

Population-based Study of Breast Cancer Survival in Cote D'Or (France): Prognostic Factors and Relative Survival

Overview
Journal Ann Oncol
Publisher Elsevier
Specialty Oncology
Date 2007 Oct 27
PMID 17962200
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Few population-based studies have reported jointly analyses of relative survival according to the following prognostic factors: tumour-node-metastasis (TNM) stage, age, number of examined and positive nodes, hormonal status, histological Scarff, Bloom and Richardson (SBR) grade, tumour extension, hormone receptor status and tumour multifocal status.

Patients And Methods: Data on female invasive breast cancer were provided by the Cote d'Or breast cancer registry. The Kaplan-Meier method and log-rank test were used to estimate and compare the survival probability at 1, 5, 10 and 15 years. The effect of prognostic factors on survival was assessed with crude and relative multivariate survival analyses.

Results: Crude survival seemed to be worse in patients aged >60 years compared with those aged 45-60 (P > 0.0001), whereas relative survival did not differ. TNM stage, histological SBR grade, progesterone receptor status, tumour multifocal status, locoregional extension and the period of diagnosis were independent prognostic factors of crude and relative survival.

Conclusion: Breast cancer is influenced by many factors. Despite the absence of any association between the number of examined nodes and overall survival in this study, the number of nodes removed, in conjunction with other prognostic factors, may be useful in selecting node-negative patients for systemic therapy.

Citing Articles

Predictors of survival rates among breast cancer patients in Ethiopia: a systematic review and meta-analysis 2024.

Mulugeta C, Emagneneh T, Kumie G, Sisay A, Abebaw N, Ayele M Arch Public Health. 2025; 83(1):30.

PMID: 39910659 PMC: 11800556. DOI: 10.1186/s13690-025-01514-6.


Survival feature and trend of female breast cancer: A comprehensive review of survival analysis from cancer registration data.

Tang D, Ye Z, Liu W, Wu J, Tan J, Zhang Y Breast. 2024; 79:103862.

PMID: 39701013 PMC: 11722932. DOI: 10.1016/j.breast.2024.103862.


What Is Known about Breast Cancer in Young Women?.

Zhu J, Charkhchi P, Adekunte S, Akbari M Cancers (Basel). 2023; 15(6).

PMID: 36980802 PMC: 10047861. DOI: 10.3390/cancers15061917.


Immunohistochemical Overexpression of Cyclin D1 in Tunisian Invasive Breast Carcinoma Women.

Bouzidi L, Makni S, Feki J, Kallel R, Graja S, Gouiaa N Arch Iran Med. 2022; 25(4):250-256.

PMID: 35942997 PMC: 11897875. DOI: 10.34172/aim.2022.41.


Prognostic factors for cancer-specific survival in 220 patients with breast cancer: A single center experience.

Tarlan M, Khazaei S, Madani S, Saleh E Cancer Rep (Hoboken). 2022; 6(1):e1675.

PMID: 35931659 PMC: 9875637. DOI: 10.1002/cnr2.1675.